NCT06770309

A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.

A Prospective, Double-blind, Randomized Controlled Clinical Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Yanbu Ke · Academic / Other
• Sex: All
• Age: 50 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if silkworm pupa powder works to improve the nutritional status of Alzheimer's disease patients. The main questions it aims to answer are: * Does silkworm pupa powder evaluate the effectiveness of silkworm pupae in improving sarcopenia, frailty and quality of life in AD patients? * Does silkworm pupa powder improve cognitive function in AD patients? Researchers will compare silkworm pupa powder to a placebo (a look-alike substance that contains no drug) to see if silkworm pupa powder works to improve the nutritional status of Alzheimer's disease patients. Participants will: * Take drug silkworm pupa powder or a placebo every day for 3 months. * Visit the clinic once every 4 weeks for checkups and tests. * Keep a diary of their daily consumption.

Conditions

• Alzheimer Disease (AD)
• Sarcopenia
• Asthenia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Silkworm pupa powder	Silkworm pupa powder, 2 times a day, two packets (12\*2 g) each time, take with warm water, before meals, for three months
DIETARY_SUPPLEMENT	Placebo	Placebo, 2 sachets (12\*2 g) twice a day, with warm water, before meals, for three months

Timeline

• Start date: 2025-01-02
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2025-01-13
• Last updated: 2025-01-13

Locations

1 site across 1 country: China